This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engle, J C
Right arrow Articles by Schleupner, C J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engle, J C
Right arrow Articles by Schleupner, C J

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 July; 28(1): 146-148

Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia.

J C Engle, P W Lifland and C J Schleupner

ABSTRACT

Ceftazidime and cefamandole were compared in the treatment of pneumonia. The median MIC of ceftazidime for all Streptococcus pneumoniae (n = 17) and Haemophilus influenzae (n = 10) isolates was 0.125 microgram/ml. All other isolates were inhibited by less than 0.5 microgram of ceftazidime per ml, with the exception of a group B streptococcus (MIC = 4 micrograms/ml). Satisfactory clinical responses were observed in 91% (20 of 22) of cefamandole-treated patients and 85% (17 of 20) of ceftazidime-treated patients.

Antimicrob Agents Chemother. 1985 July; 28(1): 146-148






Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»